CN1610738A - 诱导中胚层干细胞,es细胞,或无限增殖化的中胚层干细胞分化成神经细胞的方法 - Google Patents
诱导中胚层干细胞,es细胞,或无限增殖化的中胚层干细胞分化成神经细胞的方法 Download PDFInfo
- Publication number
- CN1610738A CN1610738A CNA028265998A CN02826599A CN1610738A CN 1610738 A CN1610738 A CN 1610738A CN A028265998 A CNA028265998 A CN A028265998A CN 02826599 A CN02826599 A CN 02826599A CN 1610738 A CN1610738 A CN 1610738A
- Authority
- CN
- China
- Prior art keywords
- cell
- stem cell
- cells
- mesodermal stem
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/44—Thiols, e.g. mercaptoethanol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
- C12N2506/1353—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/04—Immortalised cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2001/009510 WO2003038074A1 (fr) | 2001-10-30 | 2001-10-30 | Procede d'induction de differenciation de cellules souches de mesoblastes ou de cellules es dans des cellules du systeme nerveux |
JPPCT/JP01/09510 | 2001-10-30 | ||
PCT/JP2002/003344 WO2003038090A1 (fr) | 2001-10-30 | 2002-04-03 | Procede d'induction de differentiation de cellules souches mesodermiques immortalisees dans les cellules du systeme nerveux |
JPPCT/JP02/03344 | 2002-04-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1610738A true CN1610738A (zh) | 2005-04-27 |
Family
ID=11737884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA028265998A Pending CN1610738A (zh) | 2001-10-30 | 2002-10-30 | 诱导中胚层干细胞,es细胞,或无限增殖化的中胚层干细胞分化成神经细胞的方法 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP4118236B2 (fr) |
KR (1) | KR101022349B1 (fr) |
CN (1) | CN1610738A (fr) |
WO (2) | WO2003038074A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101294146B (zh) * | 2007-04-28 | 2011-05-18 | 中国科学院上海生命科学研究院 | 诱导神经干细胞分化的系统及诱导方法 |
CN112746057A (zh) * | 2020-12-25 | 2021-05-04 | 中国人民解放军海军军医大学 | 于体外将人多能干细胞诱导为神经中胚层祖细胞并维持自我更新的培养体系、方法及应用 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1449439A (zh) | 2000-06-26 | 2003-10-15 | 株式会社雷诺再生医学研究所 | 细胞级分包括能分化为神经细胞的细胞 |
WO2014054917A1 (fr) * | 2012-10-05 | 2014-04-10 | 사회복지법인 삼성생명공익재단 | Composition comprenant un sérum ischémique pour favoriser l'activation d'une cellule souche et procédé favorisant l'activation d'une cellule souche |
BR112015018923B1 (pt) | 2013-02-06 | 2022-03-03 | Nc Medical Research Inc | Métodos in vitro de produção de subpopulação heterogênea de células de medula óssea e para otimizar protocolo experimental para isolar população de células que trata neurodegeneração causada por acidente vascular cerebral isquêmico |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2395950A1 (fr) * | 1999-12-28 | 2001-07-05 | Kyowa Hakko Kogyo Co., Ltd. | Cellules pouvant induire une differenciation dans des cellules du muscle cardiaque |
-
2001
- 2001-10-30 WO PCT/JP2001/009510 patent/WO2003038074A1/fr active Application Filing
-
2002
- 2002-04-03 WO PCT/JP2002/003344 patent/WO2003038090A1/fr active Application Filing
- 2002-10-30 CN CNA028265998A patent/CN1610738A/zh active Pending
- 2002-10-30 KR KR1020047006637A patent/KR101022349B1/ko not_active IP Right Cessation
- 2002-10-30 JP JP2003540340A patent/JP4118236B2/ja not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101294146B (zh) * | 2007-04-28 | 2011-05-18 | 中国科学院上海生命科学研究院 | 诱导神经干细胞分化的系统及诱导方法 |
CN112746057A (zh) * | 2020-12-25 | 2021-05-04 | 中国人民解放军海军军医大学 | 于体外将人多能干细胞诱导为神经中胚层祖细胞并维持自我更新的培养体系、方法及应用 |
Also Published As
Publication number | Publication date |
---|---|
WO2003038074A1 (fr) | 2003-05-08 |
KR20040062610A (ko) | 2004-07-07 |
KR101022349B1 (ko) | 2011-03-22 |
WO2003038090A1 (fr) | 2003-05-08 |
JPWO2003038075A1 (ja) | 2005-02-24 |
JP4118236B2 (ja) | 2008-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2465653C (fr) | Procede permettant d'induire une differenciation de cellules souches mesodermiques, de cellules es ou de cellules souches mesodermiques immortalisees dans des cellules du systeme nerveux | |
US7807461B2 (en) | Multipotent stem cells derived from human adipose tissue and cellular therapeutic agents comprising the same | |
US8093047B2 (en) | Induction of myocardial cell from mammalian bone marrow cell or cord blood-derived cell and fat tissue | |
JP7055638B2 (ja) | 幹細胞からの筋肉系列細胞の生成 | |
CN1636054A (zh) | 来自人胚胎干细胞的间充质细胞和成骨细胞 | |
CN1860222A (zh) | 用于临床和商业用途的干细胞 | |
CN103930542A (zh) | 棕色脂肪细胞组合物及方法 | |
JP2004057198A (ja) | 多能性体細胞 | |
WO2010069204A1 (fr) | Cellules souches pluripotentes, procédé pour la préparation de celles-ci et utilisations de celles-ci | |
RU2433172C2 (ru) | Способ получения гомогенной популяции стволовых клеток и ее применение | |
US20090162326A1 (en) | Method for isolating stem cells and stem cells derived from a pad-like tissue of teeth | |
JP2004511266A (ja) | 間葉間質細胞に対する治療的利用法 | |
CN1961068A (zh) | 骨髓基质细胞培养神经干细胞的方法和组合物 | |
CN109628388B (zh) | 用消化酶组合物从胎盘血管分离间充质干细胞 | |
CN1778905A (zh) | 一种脂肪间充质干细胞的分离培养方法及其应用 | |
CN114214272A (zh) | 一种诱导脐带间充质干细胞分化心肌细胞的方法、培养基及其应用 | |
JPWO2006028049A1 (ja) | アストロサイト様細胞馴化培地の製造方法 | |
CN1610738A (zh) | 诱导中胚层干细胞,es细胞,或无限增殖化的中胚层干细胞分化成神经细胞的方法 | |
US20040208858A1 (en) | Therapeutic uses for mesenchymal stromal cells | |
KR101738715B1 (ko) | 식물 줄기세포 또는 식물 역분화 줄기 세포의 추출물을 이용한 맞춤형 만능줄기세포의 유도 방법 및 상기 방법에 의해 제조된 만능줄기세포 | |
WO2013123607A1 (fr) | Procédé de culture in vitro sans sérum et milieu de culture pour cellules souches adultes | |
JP2022540579A (ja) | cP1Pまたはその薬学的に許容可能な塩を有効成分として含む幹細胞増殖促進用組成物 | |
JP2021518118A (ja) | 神経幹細胞の高効率分離培養方法 | |
Guan et al. | Ischemia, immunosuppression, and SSEA‐1‐negative cells all contribute to tumors resulting from mouse embryonic stem cell‐derived neural progenitor transplantation | |
WO2022244502A1 (fr) | Cellules ayant la capacité d'induire des appendices cutanés, et leur procédé de production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |